BLAIR WILLIAM & CO/IL - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$854,467
+27.3%
15,017
-11.5%
0.00%
+33.3%
Q3 2022$671,000
-10.7%
16,977
-0.6%
0.00%0.0%
Q2 2022$751,000
-6.4%
17,073
-15.1%
0.00%0.0%
Q1 2022$802,000
-1.5%
20,098
-0.8%
0.00%0.0%
Q4 2021$814,000
-1.0%
20,251
+0.2%
0.00%0.0%
Q3 2021$822,000
-6.9%
20,217
+3.9%
0.00%0.0%
Q2 2021$883,000
-0.1%
19,452
-8.3%
0.00%0.0%
Q1 2021$884,000
-14.6%
21,203
-12.5%
0.00%
-25.0%
Q4 2020$1,035,000
+47.2%
24,228
-9.4%
0.00%
+33.3%
Q3 2020$703,000
-5.9%
26,750
-4.0%
0.00%
-25.0%
Q2 2020$747,000
+57.3%
27,866
+5.5%
0.00%
+33.3%
Q1 2020$475,000
+25.0%
26,413
+23.2%
0.00%
+50.0%
Q4 2019$380,000
-42.9%
21,443
-68.9%
0.00%
+100.0%
Q4 2014$665,000
+5.9%
69,0010.0%0.00%0.0%
Q3 2014$628,000
-7.8%
69,0010.0%0.00%0.0%
Q2 2014$681,000
-22.3%
69,0010.0%0.00%0.0%
Q1 2014$876,000
-14.6%
69,001
+0.7%
0.00%
-50.0%
Q4 2013$1,026,000
+35.9%
68,5010.0%0.00%
+100.0%
Q3 2013$755,000
+38.8%
68,5010.0%0.00%0.0%
Q2 2013$544,00068,5010.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders